Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shayan Cheraghlou

Showing results (21-30 of 68) with videos related to

Pageof 7
Sort By:
JAMA Dermatology|June 11, 2020
Clarification Regarding Noninferiority and a Discussion of Model Selection and Treatment Effects in Observational Research-ReplyShayan Cheraghlou, George O Agogo, Michael Girardi
The Australasian Journal of Dermatology|October 25, 2023
Fostering innovation as a pillar of academic advancement in medicine: Strategies for incentivizing innovation in academic dermatologyVignesh Ramachandran, Vartan Pahalyants, Shayan Cheraghlou, et al.
Clinical and Experimental Dermatology|September 16, 2023
Revolutionizing dermatology residency: artificial intelligence for knowledge and clinical milestones assessmentVignesh Ramachandran, Neil Jairath, Shayan Cheraghlou, et al.
Journal of the American Academy of Dermatology|May 11, 2020
Utilization, cost, and provider trends in patch testing among Medicare beneficiaries in the United States from 2012 to 2017Shayan Cheraghlou, Kalman L Watsky, Jeffrey M Cohen
Journal of the American Academy of Dermatology|March 28, 2021
Characterization of outpatient visits and treatments for urticaria in the United States adult population between 1998 and 2016Nelson Ugwu, Shayan Cheraghlou, Hao Feng, et al.
The Yale Journal of Biology and Medicine|July 5, 2022
Trends in the Cost and Utilization of Omalizumab in the Medicare Population: 2013-2017Shayan Cheraghlou, Nelson Ugwu, Beverly Yu, et al.
The Journal of Dermatological Treatment|May 5, 2022
Provider-level prescription patterns among dermatologists utilizing injectable biologics in psoriasis treatmentNelson Ugwu, Shayan Cheraghlou, Hao Feng, et al.
The Australasian Journal of Dermatology|May 24, 2021
A machine-learning modified CART algorithm informs Merkel cell carcinoma prognosisShayan Cheraghlou, Praneeth Sadda, George O Agogo, et al.
JAMA Dermatology|September 26, 2019
Comparison of Survival After Mohs Micrographic Surgery vs Wide Margin Excision for Early-Stage Invasive MelanomaShayan Cheraghlou, Sean R Christensen, George O Agogo, et al.
JAMA Dermatology|March 31, 2021
Association of Treatment Facility Characteristics With Overall Survival After Mohs Micrographic Surgery for T1a-T2a Invasive MelanomaShayan Cheraghlou, Sean R Christensen, David J Leffell, et al.
Pageof 7

Showing results (21-30 of 68) with videos related to

Sort By:
Pageof 7
JAMA Dermatology|June 11, 2020
Clarification Regarding Noninferiority and a Discussion of Model Selection and Treatment Effects in Observational Research-ReplyShayan Cheraghlou, George O Agogo, Michael Girardi
The Australasian Journal of Dermatology|October 25, 2023
Fostering innovation as a pillar of academic advancement in medicine: Strategies for incentivizing innovation in academic dermatologyVignesh Ramachandran, Vartan Pahalyants, Shayan Cheraghlou, et al.
Clinical and Experimental Dermatology|September 16, 2023
Revolutionizing dermatology residency: artificial intelligence for knowledge and clinical milestones assessmentVignesh Ramachandran, Neil Jairath, Shayan Cheraghlou, et al.
Journal of the American Academy of Dermatology|May 11, 2020
Utilization, cost, and provider trends in patch testing among Medicare beneficiaries in the United States from 2012 to 2017Shayan Cheraghlou, Kalman L Watsky, Jeffrey M Cohen
Journal of the American Academy of Dermatology|March 28, 2021
Characterization of outpatient visits and treatments for urticaria in the United States adult population between 1998 and 2016Nelson Ugwu, Shayan Cheraghlou, Hao Feng, et al.
The Yale Journal of Biology and Medicine|July 5, 2022
Trends in the Cost and Utilization of Omalizumab in the Medicare Population: 2013-2017Shayan Cheraghlou, Nelson Ugwu, Beverly Yu, et al.
The Journal of Dermatological Treatment|May 5, 2022
Provider-level prescription patterns among dermatologists utilizing injectable biologics in psoriasis treatmentNelson Ugwu, Shayan Cheraghlou, Hao Feng, et al.
The Australasian Journal of Dermatology|May 24, 2021
A machine-learning modified CART algorithm informs Merkel cell carcinoma prognosisShayan Cheraghlou, Praneeth Sadda, George O Agogo, et al.
JAMA Dermatology|September 26, 2019
Comparison of Survival After Mohs Micrographic Surgery vs Wide Margin Excision for Early-Stage Invasive MelanomaShayan Cheraghlou, Sean R Christensen, George O Agogo, et al.
JAMA Dermatology|March 31, 2021
Association of Treatment Facility Characteristics With Overall Survival After Mohs Micrographic Surgery for T1a-T2a Invasive MelanomaShayan Cheraghlou, Sean R Christensen, David J Leffell, et al.
Pageof 7